Overview

IDEA-033 Open Label Study

Status:
Completed

Trial end date:
2008-04-01

Target enrollment:

Participant gender:

Summary

The main aim of the study is to evaluate safety, efficacy, compliance, and usage of epicutaneously applied IDEA-033 in joint / musculoskeletal pain or soft tissue inflammation.

Phase:

Phase 3

Details

Lead Sponsor:

IDEA AG